AI assistant
Sending…
TITOMIC LIMITED — Earnings Release 2024
Aug 29, 2024
65963_rns_2024-08-29_7aa92838-74f0-4542-b44c-2f8dae3d74ca.pdf
Earnings Release
Open in viewerOpens in your device viewer
Titomic Limited Appendix 4E
1. Company details
Name of entity Titomic Limited ABN: 77 602 793 644 Reporting period: For the year ended 30 June 2024 Previous period: For the year ended 30 June 2023
2. Results for announcement to the market
| $ | ||||
|---|---|---|---|---|
| Revenues from ordinary activities | up | 71.5% | to | 7,697,370 |
| Loss from ordinary activities after tax | down | 24.3% | to | (11,892,164) |
| Total comprehensive loss attributable to owners | down | 23.4% | to | (11,994,468) |
3. Distributions
Current period
There were no dividends paid, recommended or declared during the current financial period.
Previous period
There were no dividends paid, recommended or declared during the current financial period.
4. Net tangible assets
| Reporting | Previous | |
|---|---|---|
| period | period | |
| Cents | Cents | |
| Net tangible assets per ordinary security | 0.0010 | (0.0030) |
5. Explanation of results
Refer to the Review of Operations within the directors' report.
6. Control gained over entities
N/A
1
Titomic Limited Appendix 4E
7. Details of associates and joint venture entities
| Reporting entity's | Contribution to | |
|---|---|---|
| percentage holding | net profit / (loss) | |
| 30-Jun-24 30-Jun-23 |
30-Jun-24 30-Jun-23 |
|
| % % |
$000s $000s |
|
| Repkon Titomic Üretim Teknolojileri Sanayi Ve Ticaret Anonim Şirketi (Repkon Joint Venture) |
49.00 49.00 |
- - |
8. Audit
The financial statements accompanying this Appendix 4E are audited and contain an independent audit report.
==> picture [111 x 37] intentionally omitted <==
Dag W.R. Stromme
Chair
30 August 2024
2
More from TITOMIC LIMITED
Regulatory Filings
2026
May 24
Regulatory Filings
2026
May 21
Board/Management Information
2026
May 18
Regulatory Filings
2026
May 17
Board/Management Information
2026
May 13
M&A Activity
2026
May 12
Share Issue/Capital Change
2026
May 10
Interim / Quarterly Report
2026
Apr 29
Director's Dealing
2026
Apr 8
Regulatory Filings
2026
Apr 1